The 720: Global Healthcare and Market Strategy Update

Goldman Sachs raises its 2030 global obesity market forecast to $114bn and increases its MSCI EM target to 2000. The report highlights tech-driven growth in Asia and defensive equity strategies in Japan.

Key Takeaways

• 1.Global anti-obesity medication (AOM) market forecast for 2030 raised by 13% to $114bn, with oral pills expected to reach 40% market share.
• 2.MSCI EM 12-month target raised to 2000, driven by the durability of the AI-exposed semiconductor cycle in North Asia.
• 3.Broadcom reports 143% YoY growth in AI Semiconductor revenue, though AI guidance came in slightly below elevated expectations.

Table of Contents

• In Focus | Global Healthcare – CDMO, Obesity
• Listen Up – GS Webcasts on the Agenda
• Japan Strategy | Unequal Equities
• Themes in Play | Meituan, Weichai Power, AU Gold Miners, Elite Material
• GS Event | HSBC, Standard Chartered
• Connections | China Consumer
• Around the world | Broadcom, EM Trader
• GS Events